Mike de Leeuw was invited to write an expert column in a special feature of ‘Het Financieel Dagblad’ covering a.o. oncology development in the Netherlands. You can read the column here.
Other
OncoLize Joins immuno-modulating consortium backed by the Dutch Cancer Foundation
20th December 2022 OncoLize has joined forces with a small but highly specialized consortium around the department of Engineered Therapeutics led by prof. dr. Jai Prakash from the University of Twente in the Netherlands. The Read more…